Profile: Altus Pharmaceuticals Inc. is focused on developing & commercializing novel protein therapeutics for patients with chronic gastrointestinal and metabolic diseases. Our product ALTU-238 is a long-acting, crystalline formulation of somatropin in development for the treatment of growth hormone deficiency (GHD) in pediatric and adult populations. Our product ALTU-237 is a recombinantly produced, orally delivered crystalline formulation of an oxalate-degrading enzyme in development for the treatment of hyperoxaluria.